Human papillomavirus's physical state and cyclin A1 promoter methylation in cervical cancer

International Journal of Gynecological Cancer

Volumn 21, Issue 5, 2011, Pages 902-906

  Yanatatsaneejit, Pattamawadee ^a   Mutirangura, Apiwat ^b   Kitkumthorn, Nakarin ^c  

^a Department Of Industrial Technology And Innovation Management   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

CCNA1 promoter methylation; Cervical cancer; Episome; HPV; Integrated

Indexed keywords

CYCLIN A1; CYCLIN A1 PROMOTER METHYLATION; HISTONE ACETYLTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER TISSUE; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN METHYLATION; UTERINE CERVIX CANCER; VIRUS TITRATION; WART VIRUS;

EID: 82955165171     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182158683     Document Type: Article

References (20)

1. Scheurer ME, Tortolero-Luna G, Adler-Storthz K. Human papillomavirus infection: Biology, epidemiology, and prevention. Int J Gynecol Cancer. 2005;15:727-746. (Pubitemid 41783075)
2. Zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology. 1991;184:9-13.
3. Tjiong MY, Out TA, Ter Schegget J, et al. Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract: A review. Int J Gynecol Cancer. 2001;11:9-17. (Pubitemid 32216903)
4. Chung CH, Gillison ML. Human papillomavirus in head and neck cancer: Its role in pathogenesis and clinical implications. Clin Cancer Res. 2009;15:6758-6762.
5. Das BC, Sharma JK, Gopalakrishna V, et al. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol. 1992;73:2327-2336.
6. Watts KJ, Thompson CH, Cossart YE, et al. Sequence variation and physical state of human papillomavirus type 16 cervical cancer isolates from Australia and New Caledonia. Int J Cancer. 2002;97:868-874. (Pubitemid 34106347)
7. Dong XP, Stubenrauch F, Beyer-Finkler E, et al. Prevalence of deletions of Y-1-binding sites in episomal HPV 16 DNA from cervical cancers. Int J Cancer. 1994;58:803-808. (Pubitemid 24306367)
8. Swan DC, Tucker RA, Tortolero-Luna G, et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol. 1999;37:1030-1034. (Pubitemid 29140610)
9. Rosty C, Sheffer M, Tsafrir D, et al. Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma. Oncogene. 2005;24:7094-7104. (Pubitemid 41573638)
10. Song Z, Li R, You N, et al. Loss of heterozygosity of the tumor suppressor gene Tg737 in the side population cells of hepatocellular carcinomas is associated with poor prognosis. Mol Biol Rep. 2010;37:4091-4101.
11. Suzuki M, Yoshino I. Aberrant methylation in nonYsmall cell lung cancer. Surg Today. 2010;40:602-607.
12. Lo KW, Huang DP. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:451-462. (Pubitemid 35370758)
13. Yang N, Nijhuis ER, Volders HH, et al. Gene promoter methylation patterns throughout the process of cervical carcinogenesis. Cell Oncol. 2010;32:131-143.
14. Kitkumthorn N, Yanatatsanajit P, Kiatpongsan S, et al. Cyclin A1 promoter hypermethylation in human papillomavirusYassociated cervical cancer. BMC Cancer. 2006;6:55.
15. Yanatatsaneejit P, Chalermchai T, Kerekhanjanarong V, et al. Promoter hypermethylation of CCNA1, RARRES1, and HRASLS3 in nasopharyngeal carcinoma. Oral Oncol. 2008;44:400-406. (Pubitemid 351391854)
16. Tokumaru Y, Yamashita K, Osada M, et al. Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing. Cancer Res. 2004;64:5982-5987. (Pubitemid 39129394)
17. Somers KD, Merrick MA, Lopez ME, et al. Frequent p53 mutations in head and neck cancer. Cancer Res. 1992;52:5997-6000.
18. Mutirangura A, Sriuranpong V, Termrunggraunglert W, et al. Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions. Br J Cancer. 1998;78:933-939. (Pubitemid 28430024)
19. Berumen J, Casas L, Segura E, et al. Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes. Int J Cancer. 1994;56:640-645. (Pubitemid 24086764)
20. Mü ller-Tidow C, Ji P, Diederichs S, et al. The cyclin A1-CDK2 complex regulates DNA double-strand break repair. Mol Cell Biol. 2004;24:8917-8928. (Pubitemid 39313897)